A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
Completed · Phase 3 · Has a placebo group
Conditions studied: Papulopustular Rosacea, Erythematotelangiectatic Rosacea
In brief
The purpose of this study is to compare the efficacy of two Metronidazole Gels 1%, in the treatment of Rosacea.
Key facts
- Study ID
- NCT02393937
- Run by
- bioRASI, LLC
- People needed
- 963
- Starts
- 2015-02-01
- Expected to finish
- 2015-10-01
- Last updated by the study team
- 2020-09-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or Female subjects with at least 18 years of age;
- Read and signed ICF;
- Clinical Diagnosis of Rosacea;
You may not qualify if…
- Females who are pregnant, lactating or of childbearing potential who are not using or do not agree to use an acceptable form of contraception;
- Any skin condition that would interfere with treatment of rosacea
- Use of prohibited medications
Where it is running
- Study site — Los Angeles, California, United States
- Study site — San Diego, California, United States
- Study site — Boca Raton, Florida, United States
- Study site — Clearwater, Florida, United States
- Study site — Miami, Florida, United States
- Study site — Miami, Florida, United States
- Study site — Miramar, Florida, United States
- Study site — Ocala, Florida, United States
- Study site — Tampa, Florida, United States
- Study site — Lexington, Kentucky, United States
- Study site — Watertown, Massachusetts, United States
- Study site — Las Vegas, Nevada, United States
- Study site — New York, New York, United States
- Study site — High Point, North Carolina, United States
- Study site — Raleigh, North Carolina, United States
- Study site — Cincinnati, Ohio, United States
- Study site — Philadelphia, Pennsylvania, United States
- Study site — Warwick, Rhode Island, United States
- Study site — Mt. Pleasant, South Carolina, United States
- Study site — Austin, Texas, United States
- Study site — El Paso, Texas, United States
- Study site — Houston, Texas, United States
- Study site — Pflugerville, Texas, United States
- Study site — Plano, Texas, United States
- Study site — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.